|
Volumn , Issue 30, 2008, Pages 34-42
|
Guidelines for renal replacement therapy in HIV-infected individuals in South Africa
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABACAVIR;
AMPRENAVIR;
AMPRENAVIR PHOSPHATE;
ANTIRETROVIRUS AGENT;
ATAZANAVIR;
CORTICOSTEROID;
CREATININE;
CYCLOSPORIN;
DELAVIRDINE;
DIDANOSINE;
EFAVIRENZ;
EMTRICITABINE;
ENFUVIRTIDE;
IMMUNOSUPPRESSIVE AGENT;
INDINAVIR;
LAMIVUDINE;
LOPINAVIR PLUS RITONAVIR;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NELFINAVIR;
NEVIRAPINE;
PROTEINASE INHIBITOR;
RAPAMYCIN;
RITONAVIR;
RNA DIRECTED DNA POLYMERASE INHIBITOR;
SAQUINAVIR;
STAVUDINE;
TACROLIMUS;
TENOFOVIR;
UNINDEXED DRUG;
ZIDOVUDINE;
ANTIVIRAL ACTIVITY;
ARTICLE;
CHILD HEALTH CARE;
CHRONIC KIDNEY DISEASE;
CLINICAL PROTOCOL;
CREATININE CLEARANCE;
DOSE KIDNEY FUNCTION RELATION;
DRUG DOSE REDUCTION;
DRUG MEGADOSE;
HEALTH PROGRAM;
HEMODIALYSIS;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY BIOPSY;
KIDNEY FAILURE;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
MIXED INFECTION;
PATIENT ATTITUDE;
PATIENT COMPLIANCE;
PATIENT SELECTION;
PERITONEAL DIALYSIS;
PSYCHOLOGIC ASSESSMENT;
RENAL REPLACEMENT THERAPY;
SOUTH AFRICA;
TREATMENT INDICATION;
UNSPECIFIED SIDE EFFECT;
|
EID: 48249104706
PISSN: 16089693
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (5)
|
References (0)
|